$96.40
-0.33[-0.34%]
At close: Apr 15
$96.40
0[0.00%]
PreMarket: 4:15PM EDT
Addus HomeCare
(NASDAQ:ADUS)Addus HomeCare Stock (NASDAQ:ADUS), Analyst Ratings, Price Targets, Predictions
Addus HomeCare Corp has a consensus price target of $95.8, established from looking at the 31 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Barclays, and RBC Capital on March 26, 2024, March 6, 2024, and February 29, 2024. With an average price target of $102.67 between Oppenheimer, Barclays, and RBC Capital, there's an implied 6.50% upside for Addus HomeCare Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Barclays
RBC Capital
William Blair
TD Cowen
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Addus HomeCare
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/26/2024 | ADUS | Buy Now | Addus HomeCare | $96.40 | 22.41% | Oppenheimer | Michael Wiederhorn | $118 → $118 | Maintains | Outperform | Get Alert |
| 03/06/2024 | ADUS | Buy Now | Addus HomeCare | $96.40 | -8.71% | Barclays | Andrew Mok | → $88 | Initiates | → Equal-Weight | Get Alert |
| 02/29/2024 | ADUS | Buy Now | Addus HomeCare | $96.40 | 5.81% | RBC Capital | Ben Hendrix | → $102 | Reiterates | Outperform → Outperform | Get Alert |
| 02/05/2024 | ADUS | Buy Now | Addus HomeCare | $96.40 | — | William Blair | Jared Haase | — | Assumes | → Outperform | Get Alert |
| 01/17/2024 | ADUS | Buy Now | Addus HomeCare | $96.40 | 22.41% | Oppenheimer | Michael Wiederhorn | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 12/12/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 8.92% | TD Cowen | Ryan Langston | → $105 | Initiates | → Outperform | Get Alert |
| 11/01/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 5.81% | RBC Capital | Ben Hendrix | $109 → $102 | Maintains | Outperform | Get Alert |
| 11/01/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 8.92% | Stephens & Co. | Scott Fidel | $110 → $105 | Maintains | Overweight | Get Alert |
| 08/02/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 22.41% | Oppenheimer | Michael Wiederhorn | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 8.92% | Raymond James | John Ransom | $100 → $105 | Maintains | Outperform | Get Alert |
| 08/02/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 14.11% | Stephens & Co. | Scott Fidel | $100 → $110 | Maintains | Overweight | Get Alert |
| 08/01/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 3.73% | Stephens & Co. | Scott Fidel | → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 06/29/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 22.41% | Oppenheimer | Michael Wiederhorn | $118 → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 05/26/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 22.41% | Oppenheimer | Michael Wiederhorn | → $118 | Reiterates | Outperform → Outperform | Get Alert |
| 05/05/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 3.73% | Raymond James | John Ransom | $125 → $100 | Maintains | Outperform | Get Alert |
| 05/03/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 13.07% | RBC Capital | Ben Hendrix | $123 → $109 | Maintains | Outperform | Get Alert |
| 05/03/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 22.41% | Oppenheimer | Michael Wiederhorn | $130 → $118 | Maintains | Outperform | Get Alert |
| 05/02/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 27.59% | Stephens & Co. | Scott Fidel | → $123 | Reiterates | → Overweight | Get Alert |
| 04/05/2023 | ADUS | Buy Now | Addus HomeCare | $96.40 | 27.59% | Stephens & Co. | Scott Fidel | → $123 | Reiterates | → Overweight | Get Alert |
FAQ
What is the target price for Addus HomeCare (ADUS)?
The latest price target for Addus HomeCare (NASDAQ: ADUS) was reported by Oppenheimer on March 26, 2024. The analyst firm set a price target for $118.00 expecting ADUS to rise to within 12 months (a possible 22.41% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Addus HomeCare (ADUS)?
The latest analyst rating for Addus HomeCare (NASDAQ: ADUS) was provided by Oppenheimer, and Addus HomeCare maintained their outperform rating.
When was the last upgrade for Addus HomeCare (ADUS)?
There is no last upgrade for Addus HomeCare.
When was the last downgrade for Addus HomeCare (ADUS)?
There is no last downgrade for Addus HomeCare.
When is the next analyst rating going to be posted or updated for Addus HomeCare (ADUS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addus HomeCare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addus HomeCare was filed on March 26, 2024 so you should expect the next rating to be made available sometime around March 26, 2025.
Is the Analyst Rating Addus HomeCare (ADUS) correct?
While ratings are subjective and will change, the latest Addus HomeCare (ADUS) rating was a maintained with a price target of $118.00 to $118.00. The current price Addus HomeCare (ADUS) is trading at is $96.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.